Dr. David Spady, M.D

NPI: 1639155005
Total Payments
$12,464
2024 Payments
$1,876
Companies
49
Transactions
584
Medicare Patients
3,137
Medicare Billing
$373,618

Payment Breakdown by Category

Food & Beverage$12,286 (98.6%)
Education$128.33 (1.0%)
Other$49.15 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $12,286 576 98.6%
Education $128.33 3 1.0%
Entertainment $49.15 1 0.4%
Unspecified $0 4 0.0%

Payments by Type

General
$12,464
580 transactions
Ownership
$0
4 transactions

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,791 147 $0 (2024)
Janssen Scientific Affairs, LLC $1,714 15 $0 (2024)
Janssen Biotech, Inc. $934.80 57 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $739.47 42 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $677.32 39 $0 (2024)
Intercept Pharmaceuticals, Inc. $505.26 14 $0 (2024)
PFIZER INC. $439.51 18 $0 (2022)
Allergan, Inc. $334.76 26 $0 (2020)
E.R. Squibb & Sons, L.L.C. $289.27 4 $0 (2024)
Valeant Pharmaceuticals North America LLC $284.29 27 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,876 66 ABBVIE INC. ($556.56)
2023 $1,499 62 AbbVie Inc. ($380.05)
2022 $1,774 70 ABBVIE INC. ($364.76)
2021 $792.35 18 Janssen Scientific Affairs, LLC ($230.49)
2020 $409.17 19 Janssen Scientific Affairs, LLC ($110.42)
2019 $1,858 84 AbbVie, Inc. ($410.31)
2018 $1,919 112 AbbVie, Inc. ($359.36)
2017 $2,336 153 AbbVie, Inc. ($511.58)

All Payment Transactions

584 individual payment records from CMS Open Payments — Page 1 of 24

Date Company Product Nature Form Amount Type
12/18/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $17.34 General
Category: IMMUNOLOGY
12/12/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $19.13 General
Category: IMMUNOLOGY
12/11/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $18.27 General
Category: Immunology
12/04/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $16.50 General
Category: GASTROENTEROLOGY
11/11/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $140.14 General
Category: Immunology
11/07/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $7.12 General
Category: GASTROENTEROLOGY
11/06/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.15 General
Category: IMMUNOLOGY
10/31/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $23.04 General
Category: INTERNAL MEDICINE
10/14/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $14.54 General
Category: IMMUNOLOGY
10/10/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $24.33 General
Category: IMMUNOLOGY
10/09/2024 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $23.47 General
Category: Neuroscience
10/08/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $20.32 General
Category: ENDOCRINOLOGY
09/30/2024 Johnson & Johnson Health Care Systems Inc. STELARA (Biological) Food and Beverage In-kind items and services $129.02 General
Category: Immunology
09/26/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $22.75 General
Category: GI
09/19/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $14.45 General
Category: GASTROENTEROLOGY
09/12/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $13.56 General
Category: ONCOLOGY
09/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.95 General
Category: Gastroenterology
09/05/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $28.13 General
Category: Immunology
08/21/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $24.42 General
Category: IMMUNOLOGY
08/15/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $19.99 General
Category: Rare Disease
08/14/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $19.30 General
Category: GASTROENTEROLOGY
08/09/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $21.84 General
Category: IMMUNOLOGY
08/06/2024 Braintree Laboratories, Inc. SUFLAVE (Drug) Food and Beverage In-kind items and services $16.62 General
Category: GI COLON PREP
08/05/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $21.58 General
Category: IMMUNOLOGY
08/05/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $6.30 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 803 827 $514,917 $98,570
2022 15 776 819 $492,620 $96,237
2021 11 806 847 $466,472 $97,953
2020 15 752 782 $388,258 $80,858
Total Patients
3,137
Total Services
3,275
Medicare Billing
$373,618
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 189 190 $202,730 $38,693 19.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 139 151 $32,767 $13,336 40.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 55 55 $42,796 $9,755 22.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 139 139 $94,520 $8,340 8.8%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 69 69 $58,443 $7,464 12.8%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 31 31 $24,211 $5,417 22.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 76 78 $11,544 $5,120 44.3%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2023 30 32 $22,432 $3,352 14.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 23 23 $7,636 $2,715 35.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 23 23 $5,037 $1,751 34.8%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 15 15 $9,735 $1,330 13.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 14 21 $3,066 $1,298 42.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 115 115 $122,705 $22,428 18.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 207 240 $52,080 $20,048 38.5%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 48 48 $37,353 $8,559 22.9%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 64 64 $54,208 $8,386 15.5%
91110 Imaging of digestive tract done from the inside of the digestive tract Office 2022 13 13 $48,815 $7,974 16.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 124 124 $82,252 $6,665 8.1%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 32 32 $24,992 $5,744 23.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 49 49 $16,268 $5,694 35.0%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2022 23 24 $16,824 $2,357 14.0%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 16 16 $11,950 $1,941 16.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 18 18 $5,004 $1,783 35.6%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2022 17 17 $11,033 $1,615 14.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 24 24 $3,552 $1,294 36.4%

About Dr. David Spady, M.D

Dr. David Spady, M.D is a Gastroenterology healthcare provider based in Southlake, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639155005.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Spady, M.D has received a total of $12,464 in payments from pharmaceutical and medical device companies, with $1,876 received in 2024. These payments were reported across 584 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($12,286).

As a Medicare-enrolled provider, Spady has provided services to 3,137 Medicare beneficiaries, totaling 3,275 services with total Medicare billing of $373,618. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Southlake, TX
  • Active Since 12/19/2005
  • Last Updated 05/16/2013
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1639155005

Products in Payments

  • STELARA (Biological) $2,350
  • Humira (Biological) $784.31
  • RINVOQ (Biological) $719.30
  • XIFAXAN (Drug) $566.66
  • OCALIVA (Drug) $462.72
  • ENTYVIO (Biological) $456.35
  • LINZESS (Drug) $348.10
  • XELJANZ (Drug) $347.97
  • ZEPOSIA (Drug) $334.06
  • SKYRIZI (Biological) $321.21
  • Creon (Drug) $298.66
  • REMICADE (Biological) $279.15
  • DUPIXENT (Biological) $264.98
  • INJECTAFER (Drug) $258.40
  • TRULANCE (Drug) $192.28
  • VIBERZI (Drug) $191.98
  • DIFICID (Drug) $184.16
  • OMVOH (Drug) $177.71
  • Entyvio (Biological) $175.72
  • LINX Reflux Management System (Device) $161.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Southlake